Table 2:
Outcome | Intervention, no. (%) | p value* | |
---|---|---|---|
Dual-hormone closed-loop delivery n = 15 |
Continuous subcutaneous insulin infusion n = 15 |
||
Patients with at least 1 hypoglycemic event† | 1 (7) | 8 (53) | 0.02 |
Patients with at least 1 nocturnal hypoglycemic event†‡ | 0 (0) | 5 (33) | 0.07 |
Patients with at least 1 exercise-induced hypoglycemic event†§ | 1 (7) | 2 (13) | 1.0 |
Nocturnal‡ plasma glucose measurements¶ | n = 363 | n = 367 | |
< 4.0 mmol/L | 2 (0.5) | 45 (12.3) | — |
< 3.3 mmol/L | 0 (0.0) | 13 (3.5) | — |
< 3.0 mmol/L | 0 (0.0) | 9 (2.5) | — |
McNemar test.
Defined as at least 1 measurement of plasma glucose concentration < 3.0 mmol/L, which was treated by oral carbohydrate.
Between the hours of 2300 and 0700.
From start of exercise to 1920.
Measurements were taken at 20-min intervals.